drug development
Inside Hims’ Earnings Call: CEO Tackles GLP-1 Compounding Concerns Head-On
In recent times, telehealth company Hims & Hers has sparked discussions about compounded GLP-1 weight loss medications. During a recent ... Read more
Exploring Medicare’s AI Modernization: Impacts on Ohio’s Hospital Antitrust Struggle
The Winter Olympics have wrapped up, which means it’s time to shift gears and look forward to the upcoming pro ... Read more
FDA Chief Prasad Reverses Staff Decision: Moderna’s Flu Vaccine Application Denied
Vinay Prasad, a leading figure at the FDA, made a significant decision recently by rejecting Moderna’s request for a new ... Read more
Unveiling the Trump Tax Strategy: How Major Health Care Giants Dodge Taxes
Hey there! Let’s dive into a pressing issue: the future of health insurance, particularly the Affordable Care Act (ACA). A ... Read more
Uncovering the Truth: Faux Price Transparency, MAGA MA Insights, and UnitedHealth’s Latest Data Breach
The pharmaceutical industry has been under scrutiny for years, especially regarding drug prices. In 2017, after President Trump took office, ... Read more
Sarepta Therapeutics’ Duchenne Therapy: What an FDA Official Says About Its Challenging Road to Market
Sarepta Therapeutics is facing tough challenges with its gene therapy for Duchenne muscular dystrophy, called Elevidys. This treatment is currently ... Read more
